Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

AstraZeneca portfolio includes new series of P2T antagonists

Feb. 18, 2000

Stroke news: DuPont gpIIb/IIIa antagonist shows promise in ischemic stroke

Feb. 16, 2000

Anti-gpIIb/IIIa MAb fragment proves effective and safe in rat model of embolic stroke

Feb. 16, 2000

FDA extends decision date for Novastan NDA to Feburary 18

Feb. 15, 2000

UroGen cleared to begin phase I human clinical trial of gene therapy for hemophilia A

Feb. 14, 2000

Sibrafiban no better than aspirin in final analysis of SYMPHONY study

Feb. 11, 2000

German investigators discover new anticoagulant compounds

Feb. 10, 2000

Integrilin stent study halted early due to positive results

Feb. 10, 2000

Long-term expression of factor VIII gene achieved in mice

Feb. 7, 2000

Patient enrollment begins in U.S. phase III trial of beraprost

Feb. 2, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...